Ym Biosciences Australia Pty Ltd.
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
Previously recorded as Cytopia Research Pty Ltd. (to 2010)
9
Ending by 2030
Jun 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 20, 2027.
Recent changes
- 1 term has ended since Aug 22, 2026
- Aug 26 US 8,084,456 Pyrazine-based tubulin inhibitors · term ended
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,030,336 | Nicotinamide-based kinase inhibitors In force · USPTO record | In force | USPTO record | |
| US 9,029,386 | Pyridine Derivatives Useful as Kinase Inhibitors In force · Medium confidence | In force | Medium confidence | |
| US 7,981,900 | 2-phenyl pyrimidines which are tubulin inhibitors In force · USPTO record | In force | USPTO record | |
| US 9,040,549 | Thiopyrimidine-Based Compounds and Uses Thereof In force · Medium confidence | In force | Medium confidence | |
| US 8,461,161 | Substituted pyrazines as inhibitors of kinase activity In force · USPTO record | In force | USPTO record | |
| US 8,354,408 | N-containing heterocyclic compounds In force · USPTO record | In force | USPTO record | |
| US 8,765,755 | N-containing heterocyclic compounds In force · USPTO record | In force | USPTO record | |
| US 9,499,560 | N-containing heterocyclic compounds In force · USPTO record | In force | USPTO record | |
| US 8,846,704 | Thiopyrimidine-based compounds and uses thereof In force · USPTO record | In force | USPTO record | |
| US 8,809,359 | Phenyl amino pyrimidine bicyclic compounds and uses thereof In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 10: 5 patents in force now held by others · 1 lapsed for an unpaid fee · 12 ended at full term · 1 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 abandoned · 2 no status recorded